Biomedical Catalyst 2025: Industry led R&D small projects

MODERATE Tx Startup

Strategy Notes

Strong sector match (biotech drug discovery innovation), but applicant is pre-seed and not yet incorporated, which may disqualify from SME requirement. Geography is secondary (UK in target list but France prioritized). Investigate SME eligibility and timeline before investing application effort.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: Up to £25 million (individual award not specified in excerpt)
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · Three independent hard blockers: (1) competition closed 11 December 2025 — today is 2026-07-09, no applications accepted; (2) lead organisation must be a UK registered SME — applicant is not yet incorporated and holds no UK entity; (3) all project work must be carried out in the UK and results exploited from or in the UK — applicant is Nigeria-based and targeting France/Île-de-France.